Public Company News

Infortrend Fuels HPC Workloads in a Government-Affiliated Laboratory in India

TAIPEI, March 12, 2024 /PRNewswire/ -- Infortrend® Technology, Inc. (TWSE: 2495), the industry-leading enterprise storage provider, empowers a government-affiliate...

2024-03-12 21:13 1686

Silicon Motion Unveils 6nm UFS 4.0 Controller for AI Smartphones, Edge Computing and Automotive Applications

Company also launches its second generation UFS3.1 controller supporting the latest high speed 3D TLC and QLC NAND TAIPEI and MILPITAS, Calif., March 12, 2024 /PRNewswire/ -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) ("Silicon Motion"), a global leader in designing and marketing NAN...

2024-03-12 21:00 1767

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin")...

2024-03-12 20:30 3138

GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

R&D Innovation to Lead the Future, Deepening Customer Value Creation * Sustained High Revenue Growth: GenScript Group's five-year CAGR stands at an impressive 30%, with a strong global operation and stable cash flow. In 2023, the group's best-in-class cell therapy product CARVYKTI®, achieved sa...

2024-03-12 20:15 2710

Lufax to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

SHANGHAI, March 12, 2024 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners inChina, today announced that it plans to release its fourth quarter and fiscal year 2023 financial results before the ma...

2024-03-12 19:00 2681

Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders

* Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a$12.50 trading price * Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close * Upon closing, Baird Medical is expected to trade...

2024-03-12 19:00 2522

NaaS Technology and CCTEB Form Strategic Partnership to Accelerate Digitalization of Charging Infrastructure Network

* The collaboration integrates NaaS' capabilities of energy assets addressing and data analytic with CCTEB's construction practices to charging station EPC, PV, battery storage upgrades and energy port upgrades, etc. * More convenient charging services and efficient energy assets operation are...

2024-03-12 17:10 1754

DouYu International Holdings Limited to Report Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024

WUHAN, China, March 12, 2024 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading game-centric live streaming platform inChina and a pioneer in the eSports value chain, today announced that it plans to release its unaudited financial results fo...

2024-03-12 16:00 1655

ATRenew Announces US$20 Million Share Repurchase Program

SHANGHAI, March 12, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced that its board of directors has authorized a share repurchase program, under whic...

2024-03-12 16:00 2406

ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results

SHANGHAI, March 12, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced its unaudited financial results for the fourth quarter and full year endedDecembe...

2024-03-12 16:00 2378

MINISO Group Announces December Quarter 2023 Unaudited Financial Results

GUANGZHOU, China, March 12, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced its unaudited financial results for the ...

2024-03-12 12:15 2510

Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®

SHANGHAI, March 11, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced that the U.S. FDA has granted an orphan drug exclusivity period of seven years for...

2024-03-12 09:28 2922

Cango Inc. Reports Fourth Quarter and Full Year 2023 Unaudited Financial Results

SHANGHAI, March 11, 2024 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform inChina, today announced its unaudited financial results for the fourth quarter and full year of 2023. Fourth Quarter 2023 Financial and Operational High...

2024-03-12 05:30 2213

Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results

DUBAI, UAE, March 11, 2024 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largestMiddle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the fourth quarter and full year endedDecem...

2024-03-12 05:00 2249

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, March 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of$50,000 has been deposited into the Company's trust account to further extend the period of time the Company has to consummate its business combination by a...

2024-03-12 04:30 1897

Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London

SHANGHAI, March 11, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present its next generation ADC platform IDDC™ and the latest study results of multiple novel ADCs (9MW2821, 7MW3711, 9MW2921) developed...

2024-03-11 22:00 1526

Yiren Digital to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024

BEIJING, March 11, 2024 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services inChina, announced that it plans to release its unaudited financial results for the fourth quarter ...

2024-03-11 20:35 2559

WiMi Developed a Lightweight Multi-sectoral Data Sharing System Based on Consortium Blockchains

BEIJING, March. 11, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed a lightweight multi-sectoral data-sharing system based on consortium blockchains. T...

2024-03-11 20:30 2619

Recon Technology Secures US$3 Million in Contracts with Newly Developed Customer for Electronic Components and Materials

BEIJING, March 11, 2024 /PRNewswire/ -- Recon Technology Ltd ("Recon" or the "Company"), aChina-based provider of oilfield services and low-carbon energy services, today announced two recently awarded bids from a newly developed oilfield-industry customer for the supply of electronic components a...

2024-03-11 20:30 2469

TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer

* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...

2024-03-11 20:00 1438
1 ... 109110111112113114115 ... 773

Week's Top Stories